Your browser doesn't support javascript.
loading
Research progress of circRNA in breast cancer drug resistance / 国际外科学杂志
International Journal of Surgery ; (12): 713-717, 2022.
Article en Zh | WPRIM | ID: wpr-954281
Biblioteca responsable: WPRO
ABSTRACT
Breast cancer is the most common cancer among women worldwide, and it seriously threatens women′s life and health. circular RNA (circRNA) play a key role in the development and drug resistance of various cancers, including breast cancer. circRNA is an endogenous RNA molecule with a single-stranded closed structure, which has unique biological characteristics and function, and is a current research hotspot. This article will review circRNA as potential biomarkers to predict breast cancer drug resistance and therapeutic targets.
Palabras clave
Texto completo: 1 Base de datos: WPRIM Idioma: Zh Revista: International Journal of Surgery Año: 2022 Tipo del documento: Article
Texto completo: 1 Base de datos: WPRIM Idioma: Zh Revista: International Journal of Surgery Año: 2022 Tipo del documento: Article